Literature DB >> 9736232

Erythrocyte superoxide dismutase activity and plasma malondialdehyde levels in children with Henoch Schönlein purpura.

G Demircin1, A Oner, Y Unver, M Bülbül, O Erdoğan.   

Abstract

Reactive oxygen molecules (ROM) have been suggested to contribute to many pathological conditions including vasculitides and renal diseases. In the present study we measured the activity of superoxide dismutase (SOD) as an antioxidant enzyme in red blood cells and the level of malondialdehyde (MDA), which is a product and an indicator of lipid peroxidation, in the plasma of 16 children (7M, 9F) with Henoch Schönlein purpura (HSP) at the onset of the disease (SOD 1 and MDA 1) and at the remission period (SOD 2 and MDA 2). The results were compared with the results of 17 healthy children studied as a control group. There was no significant difference for SOD activities between the patients in each period and the control group (p > 0.05). There was a statistically significant difference between MDA 1 and MDA 2 levels (p < 0.01), each of which were also significantly different from the MDA levels of control group (p < 0.001 and p < 0.01, respectively). The effect of ROMs on different clinical conditions of HSP was also examined and lipid peroxidation was found to be increased more in patients with renal involvement. It is concluded that oxidant stress especially lipid peroxidation plays an important role in the pathogenesis of HSP and in development of renal injury.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9736232     DOI: 10.1080/080352598750013617

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  4 in total

1.  Neutrophil activation, protein oxidation and ceruloplasmin levels in children with Henoch-Schönlein purpura.

Authors:  Aydin Ece; Selvi Kelekçi; Aşkin Hekimoğlu; Halil Kocamaz; Hasan Balik; Ilyas Yolbaş; Ozcan Erel
Journal:  Pediatr Nephrol       Date:  2007-04-03       Impact factor: 3.714

2.  Elevated plasma advanced oxidation protein products in children with Henoch-Schonlein purpura.

Authors:  Nurcan Keskin; Mahmut Civilibal; Murat Elevli; Macit Koldas; Nilgun Selcuk Duru; Humeyra Ozturk
Journal:  Pediatr Nephrol       Date:  2011-05-08       Impact factor: 3.714

3.  Antioxidant enzyme activities, lipid peroxidation, and total antioxidant status in children with Henoch-Schönlein purpura.

Authors:  Aydin Ece; Selvi Kelekçi; Halil Kocamaz; Aşkin Hekimoğlu; Hasan Balik; Ilyas Yolbaş; Ozcan Erel
Journal:  Clin Rheumatol       Date:  2007-07-24       Impact factor: 2.980

4.  Evaluation of oxidative stress and erythrocyte properties in children with henoch-shoenlein purpura.

Authors:  Dolunay Gurses; Nusret Parlaz; Melek Bor-Kucukatay; Vural Kucukatay; Gulten Erken
Journal:  Iran J Pediatr       Date:  2014-04       Impact factor: 0.364

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.